316 related articles for article (PubMed ID: 33968738)
1. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
He Y; Liu R; Yang M; Bi W; Zhou L; Zhang S; Jin J; Liang X; Zhang P
Front Oncol; 2021; 11():639600. PubMed ID: 33968738
[TBL] [Abstract][Full Text] [Related]
2. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.
Fei H; Chen S; Xu C
Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704
[TBL] [Abstract][Full Text] [Related]
3. Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma.
Luo X; Feng L; Xu W; Bai X; Wu M
Evol Bioinform Online; 2021; 17():11769343211009898. PubMed ID: 33911849
[TBL] [Abstract][Full Text] [Related]
4. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.
Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X
Front Oncol; 2023; 13():1199608. PubMed ID: 37409245
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Identification of Key Genes for the Development and Prognosis of Lung Adenocarcinoma.
Luo X; Xu JG; Wang Z; Wang X; Zhu Q; Zhao J; Bian L
Inquiry; 2022; 59():469580221096259. PubMed ID: 35635202
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
Guo Z; Huang J; Wang Y; Liu XP; Li W; Yao J; Li S; Hu W
Front Genet; 2020; 11():547. PubMed ID: 32595698
[TBL] [Abstract][Full Text] [Related]
8. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
9. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Deng H; Hang Q; Shen D; Zhang Y; Chen M
Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of differentially expressed genes in tumor and paracancerous tissues of patients with lung adenocarcinoma.
Yang R; Zhou Y; Du C; Wu Y
J Thorac Dis; 2020 Dec; 12(12):7355-7364. PubMed ID: 33447425
[TBL] [Abstract][Full Text] [Related]
11. Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma.
Wang X; Luo X; Wang Z; Wang Y; Zhao J; Bian L
Heliyon; 2023 Sep; 9(9):e19114. PubMed ID: 37662825
[TBL] [Abstract][Full Text] [Related]
12.
Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
Front Oncol; 2021; 11():754290. PubMed ID: 34745988
[TBL] [Abstract][Full Text] [Related]
13. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma.
Yi X; Luo L; Zhu Y; Deng H; Liao H; Shen Y; Zheng Y
Cancer Cell Int; 2022 Oct; 22(1):324. PubMed ID: 36266702
[TBL] [Abstract][Full Text] [Related]
14. NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma.
Zhao C; Liu J; Zhou H; Qian X; Sun H; Chen X; Zheng M; Bian T; Liu L; Liu Y; Zhang J
Cancer Cell Int; 2021 Apr; 21(1):228. PubMed ID: 33879165
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis.
Guo Q; Ke XX; Liu Z; Gao WL; Fang SX; Chen C; Song YX; Han H; Lu HL; Xu G
Front Genet; 2020; 11():242. PubMed ID: 32265985
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
17. Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways.
Zhang J; Wang X; Song C; Li Q
BMC Cancer; 2023 Feb; 23(1):152. PubMed ID: 36782138
[TBL] [Abstract][Full Text] [Related]
18. Non-SMC condensin I complex subunit H (NCAPH), a regulator of cell cycle, predicts poor prognosis in lung adenocarcinoma patients: a study mainly based on TCGA and GEO database.
Zhou W; Hu J; Zhao J
Transl Cancer Res; 2020 Dec; 9(12):7572-7587. PubMed ID: 35117357
[TBL] [Abstract][Full Text] [Related]
19. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma.
Chen S; Lu Z; Chen X; Wu X; Tu H; Yu L; Xiao Z
Oncol Lett; 2020 Nov; 20(5):147. PubMed ID: 32934715
[TBL] [Abstract][Full Text] [Related]
20. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]